Shi LZ[Author] - Search Results

Year	Number of Results
1986	1
1987	1
1995	1
2005	1
2006	3
2007	6
2008	5
2009	4
2010	1
2011	6
2012	11
2013	8
2014	5
2015	3
2016	3
2017	2
2018	5
2019	5
2020	6
2021	4
2022	6
2023	6
2024	3

1

Machine Learning-Based Prognostic Model for Patients After Lung Transplantation.

Tian D, Yan HJ, Huang H, Zuo YJ, Liu MZ, Zhao J, Wu B, Shi LZ, Chen JY. Tian D, et al. Among authors: shi lz. JAMA Netw Open. 2023 May 1;6(5):e2312022. doi: 10.1001/jamanetworkopen.2023.12022. JAMA Netw Open. 2023. PMID: 37145595 Free PMC article.

2

The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation.

Wang R, Dillon CP, Shi LZ, Milasta S, Carter R, Finkelstein D, McCormick LL, Fitzgerald P, Chi H, Munger J, Green DR. Wang R, et al. Among authors: shi lz. Immunity. 2011 Dec 23;35(6):871-82. doi: 10.1016/j.immuni.2011.09.021. Immunity. 2011. PMID: 22195744 Free PMC article.

3

Loss of IFN-γ Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy.

Gao J, Shi LZ, Zhao H, Chen J, Xiong L, He Q, Chen T, Roszik J, Bernatchez C, Woodman SE, Chen PL, Hwu P, Allison JP, Futreal A, Wargo JA, Sharma P. Gao J, et al. Among authors: shi lz. Cell. 2016 Oct 6;167(2):397-404.e9. doi: 10.1016/j.cell.2016.08.069. Epub 2016 Sep 22. Cell. 2016. PMID: 27667683 Free PMC article.

4

Editorial: Immune Cell Lineage Reprogramming in Cancer.

Leavenworth JW, Shi LZ, Wang X, Wei H. Leavenworth JW, et al. Among authors: shi lz. Front Immunol. 2022 Jan 19;12:838464. doi: 10.3389/fimmu.2021.838464. eCollection 2021. Front Immunol. 2022. PMID: 35126385 Free PMC article. No abstract available.

5

HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells.

Shi LZ, Wang R, Huang G, Vogel P, Neale G, Green DR, Chi H. Shi LZ, et al. J Exp Med. 2011 Jul 4;208(7):1367-76. doi: 10.1084/jem.20110278. Epub 2011 Jun 27. J Exp Med. 2011. PMID: 21708926 Free PMC article.

6

Metabolic regulation of T_H17 cells.

Shen H, Shi LZ. Shen H, et al. Among authors: shi lz. Mol Immunol. 2019 May;109:81-87. doi: 10.1016/j.molimm.2019.03.005. Epub 2019 Mar 20. Mol Immunol. 2019. PMID: 30903829 Free PMC article. Review.

7

HiJAKing Immunotherapy-Resistant Melanoma for a Cure.

Shi LZ, Shen H, Ojo OA, Bonner JA. Shi LZ, et al. Oncologist. 2023 Mar 17;28(3):196-198. doi: 10.1093/oncolo/oyac270. Oncologist. 2023. PMID: 36640142 Free PMC article.

8

B cell-T cell interplay in immune regulation: A focus on follicular regulatory T and regulatory B cell functions.

Tan D, Yin W, Guan F, Zeng W, Lee P, Candotti F, James LK, Saraiva Camara NO, Haeryfar SMM, Chen Y, Benlagha K, Shi LZ, Lei J, Gong Q, Liu Z, Liu C. Tan D, et al. Among authors: shi lz. Front Cell Dev Biol. 2022 Sep 23;10:991840. doi: 10.3389/fcell.2022.991840. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 36211467 Free PMC article. Review.

9

Gfi1: a unique controller of T(reg) cells.

Shi LZ, Chi H. Shi LZ, et al. Cell Cycle. 2013 Dec 1;12(23):3581-2. doi: 10.4161/cc.26824. Epub 2013 Oct 21. Cell Cycle. 2013. PMID: 24131921 Free PMC article. No abstract available.

10

Predictive biomarkers for immune checkpoint blockade and opportunities for combination therapies.

Shen H, Yang ES, Conry M, Fiveash J, Contreras C, Bonner JA, Shi LZ. Shen H, et al. Among authors: shi lz. Genes Dis. 2019 Jul 3;6(3):232-246. doi: 10.1016/j.gendis.2019.06.006. eCollection 2019 Sep. Genes Dis. 2019. PMID: 32042863 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

89 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

89 results

Results by year